Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.

Tebas P, Martinez Ruiz R, Roman F, Mendaza P, Rodriguez Diaz JC, Daza R, de Letona JM.

J Infect Dis. 1991 Jan;163(1):204-5. No abstract available.

PMID:
1984473
2.

Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.

Peterson LR, Quick JN, Jensen B, Homann S, Johnson S, Tenquist J, Shanholtzer C, Petzel RA, Sinn L, Gerding DN.

Arch Intern Med. 1990 Oct;150(10):2151-5.

PMID:
2222100
3.

Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.

Antimicrob Agents Chemother. 1989 Apr;33(4):519-21.

4.

Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases.

Simon GL, Smith RH, Sande MA.

Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S507-8. No abstract available.

PMID:
6635441
5.

The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis.

Kaatz GW, Barriere SL, Schaberg DR, Fekety R.

J Antimicrob Chemother. 1987 Nov;20(5):753-8.

PMID:
3429376
6.

Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.

Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF.

J Antimicrob Chemother. 1994 Apr;33(4):785-94.

PMID:
8056697
8.

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.

Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.

Antimicrob Agents Chemother. 1988 May;32(5):747-51.

9.
10.

Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.

Dworkin RJ, Lee BL, Sande MA, Chambers HF.

Lancet. 1989 Nov 4;2(8671):1071-3.

PMID:
2572799
11.

Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.

Perronne CM, Malinverni R, Glauser MP.

Antimicrob Agents Chemother. 1987 Apr;31(4):539-43.

12.

Ciprofloxacin resistance and staphylococcal endocarditis.

[No authors listed]

Lancet. 1989 Dec 23-30;2(8678-8679):1525-6. No abstract available.

PMID:
2574800
13.

Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.

Dailey CF, Pagano PJ, Buchanan LV, Paquette JA, Haas JV, Gibson JK.

Antimicrob Agents Chemother. 2003 Aug;47(8):2655-8.

14.

Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.

Antimicrob Agents Chemother. 1989 Aug;33(8):1184-7.

15.

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.

Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR.

Antimicrob Agents Chemother. 1990 Feb;34(2):273-6.

16.

Treatment of Staphylococcus aureus prosthetic valve endocarditis.

Hassoun A.

Am J Med. 2007 Mar;120(3):e9; author reply e11. No abstract available.

PMID:
17349434
17.

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.

Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, Sisson SD, Tidmore WC, vom Eigen KA, Goodman SN, Lietman PS, Petty BG, Flexner C.

Am J Med. 1996 Jul;101(1):68-76.

PMID:
8686718
18.

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.

Kaatz GW, Barriere SL, Schaberg DR, Fekety R.

Antimicrob Agents Chemother. 1987 Apr;31(4):527-30.

19.

[Mitral endocarditis caused by Staphylococcus aureus resistant to methicillin, aminoglucosides and rifampicin: description of 2 cases with fatal course].

Serrano R, Miró JM, Marco F, Cartañá R, Muñoz J, Sacanellas E, Trilla A, Soriano E.

Med Clin (Barc). 1993 Oct 2;101(10):379-82. Spanish.

PMID:
8231345

Supplemental Content

Support Center